News | ECG | February 16, 2021

New ECG System Eliminated Wire Leads to Simplify Standard 12-Lead ECG 

Company says it reduces patient contact during the COVID-19 pandemic and is the world’s first 12-lead ECG service for home use

The QT Medical PCA 500 12-lead ECG system uses a unique wearable wrap that contains all the leads and eliminated the need to connect separate wire electrodes to the patient. The simplicfication of lead placement enables the system to be used by patients at home.

The QT Medical PCA 500 12-lead ECG system uses a unique wearable wrap that contains all the leads and eliminated the need to connect separate wire electrodes to the patient. The simplicfication of lead placement enables the system to be used by patients at home.


February 16, 2021 — QT Medical recently announced the launch of Xpress ECG service, the world’s first 12-lead ECG home test, to help reduce the risk of exposure to COVID-19 by bringing ECG tests to patients’ homes. The 12-lead ECG (EKG) with PCA 500 and makes it available for use by both healthcare professionals and patients. 

In response to the surge of needs in the COVID-19 pandemic, the company offers Xpress ECG service, which makes ECG tests accessible and affordable, while decreasing the risk of exposure to potential infections. The physicians can now simply order Xpress ECG tests online and the ECG kits will be shipped to the patients in 1 to 3 business days.

The ECG tests are performed using PCA 500, a complete 12-lead ECG platform that includes a super-compact recorder, prepositioned electrode strip, mobile app, HIPAA-compliant cloud and preliminary interpretation. 

“This new exclusive service offers patients the ability to monitor their own heart health, allows healthcare providers to continue providing quality of care while maximizing revenue, and minimizing cost and risks for the healthcare system. Xpress ECG enables millions of patients with heart diseases to manage their health from the comfort of their homes,” said Ruey-Kang Chang, M.D., CEO of QT Medical Inc.

With the new CPT codes (e.g. 99457), an ECG test done by patients at home can be reimbursed 3 times higher than an ECG test done in the doctor’s office. When the doctor orders an Xpress ECG test, a kit including a PCA 500 recorder, an electrode strip, and a postage-paid return envelope will be shipped to the patients. QT Medical had previously conducted a clinical trial, which showed minimal or no training is needed to use PCA 500. All ECGs are automatically transmitted to the cloud, and a preliminary computer interpretation is instantly available. Through the cloud, physicians can review the results from anywhere to make informed decisions.

Unlike dozens of single lead ECG devices on the market, PCA 500 is hospital grade 12-lead ECG, which is medical standard for diagnosing a wide variety of heart diseases such as heart attacks, long QT syndrome, myocarditis, adverse effects of medications, cardiomyopathy, etc. Using Xpress ECG, healthcare providers can minimize the risk of infection by not sending patients to labs or hospitals for ECG tests. Telehealth patients who need an ECG test will be able to get a full 12-lead ECG without leaving their homes.

Xpress ECG is a medical standard 12-lead ECG test, using PCA 500, ordered by healthcare providers. Patients should consult their physicians to decide if PCA 500 is right for them.

QT Medical is a medtech company with a focus on high quality 12-lead diagnostic ECG for use by healthcare professionals and patients. Cleared by the FDA in 2018 and CE marked in 2020, PCA 500 is the world’s most compact 12-lead ECG system. With its simplicity, ease of use, mobile technology and cloud management, PCA 500 brings hospital-grade ECG to homes, and enables doctors to make informed decisions anywhere, anytime. 

For more information: www.qtmedical.com


Related Content

News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
News | ECG

Jan. 8, 2026 — AccurKardia recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the ...

Home January 15, 2026
Home
News | ECG

Jan. 13, 2026 — AliveCor has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI ...

Home January 14, 2026
Home
News | ECG

Oct. 8, 2025 — Viz.ai recently launched Viz ACS, a new solution in the Viz Cardio Suite. Designed to unite the acute ...

Home October 09, 2025
Home
News | ECG

Aug. 14, 2025 — During HeartBeam, Inc.'s second quarter 2025 earnings conference call, the medical technology company ...

Home August 15, 2025
Home
News | ECG

July 24, 2025 — Royal Philips has announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory ...

Home July 24, 2025
Home
Subscribe Now